Nearly 400 institutions are "watching" this company in the first quarter

Wind data shows that in the first quarter of 2026, 1,351 listed companies received institutional research visits, among which JINDA Heavy Industry cumulative hosted nearly 400 institutions for research visits, making it the most favored stock among institutions in the first quarter.

Judging by secondary market performance, the A-share market fluctuated and corrected in the first quarter, but among listed companies that received institutional research, some stocks such as Oke YII saw their share prices double, and the independent rally they triggered has attracted investors’ attention. From an industry perspective, the stocks with the highest share-price gains are distributed relatively densely across sectors such as biopharmaceuticals and electronic components.

**　　Nearly 400 companies swarm for research visits to JINDA Heavy Industry**

Wind data shows that in the first quarter of 2026, a total of 1,351 A-share listed companies received institutional research visits, accounting for nearly one quarter of the total number of A-share listed companies. In terms of individual companies, JINDA Heavy Industry累计 received 394 institutional research visits, making it the most favored listed company in the first quarter. Research meeting minutes indicate that during the visits, topics such as JINDA Heavy Industry’s expectations regarding the tendering progress for offshore wind bids in Europe and other overseas markets in 2026 were emphasized.

JINDA Heavy Industry stated that, besides the UK, Germany, Japan, the Netherlands, and Poland are also the company’s key markets. The company has strong delivery performance in projects in Germany’s offshore wind base-field domain, and it has already secured quays at Cuxhaven Port in Germany, which will be used to carry out localized services in the future. Some offshore wind power projects in Japan that have already been approved are expected to be awarded contracts in phases this year. With limited capacity for local infrastructure supply, the company has a good opportunity to enter the market and is currently actively participating in bidding. In the Polish market, the company has completed its layout, has staff reserves, and already has project experience in localized installation and inspection.

In addition, in the first quarter, both Mairui Medical and Tianshun Wind Energy received more than 300 institutional research visits, with similarly high attention. Judging from the research meeting minutes disclosed by the companies, Mairui Medical was asked about the reasons behind the significant decline in profit margins in 2025, among other topics. For Tianshun Wind Energy, questions included the company’s nominal production capacity situation in 2026, and the positioning of the company’s product or service model for overseas business, among other questions.

Mairui Medical responded that its net profit margin fell by 6.57 percentage points in 2025. Among them, the most core impact factor was a decline in gross margin of 2.8 percentage points. The underlying reason was that in the domestic business, the gross margins of its three major product lines declined to different degrees due to product price decreases, while the gross margin of the international business remained steady. Tianshun Wind Energy said that its German factory mainly produces large monopiles locally for Europe, and by leveraging the large stockyards at the German factory and coordinating with domestic factories, it achieves global delivery capability, enabling assembly of some products locally in Europe.

From the industry distribution of listed companies that received institutional research visits in the first quarter, stocks in the four industries—electronics, machinery and equipment, biopharmaceuticals, and power equipment—were the institutions’ “top picks,” with each having more than 110 companies receiving institutional research visits. In sectors such as chemical raw materials, computer, and automobiles, more than 80 companies in each had institutional research visits in the first quarter, and attention was similarly high.

**　　Five stocks doubled against the trend in the first quarter**

Looking back at the overall performance of the A-share market in the first quarter, the three major stock indices experienced clear pullbacks, and many companies’ share prices also fell along with it. However, based on the earlier situation of listed companies that received institutional research visits in the first quarter, there were also some companies whose share prices rose against the trend, even going on to deliver an independent rally that doubled.

On April 1, Oke YII’s share price rebounded by nearly 10%. Its cumulative share-price gain in the first quarter was 147.22%, making it the best-performing stock among the listed companies that received institutional research visits during the same period. According to available information, Oke YII is specialized in the R&D, production, and sales of CNC cutting tools and cemented carbide products. In the first quarter, it cumulatively received institutional research visits from 19 institutions. The research meeting minutes disclosed by the company show that topics such as what role AI plays in cutting tools and what arrangements the company has in robot-related industrial chains were of interest to institutions.

Oke YII stated that the application of AI in cutting tools is profoundly changing the entire cutting-tool lifecycle—from design, manufacturing, to maintenance. For example, AI algorithms can automatically generate optimal geometric shapes based on the cutting tool’s operating conditions, which can significantly shorten design cycles and create high-performance structures that are difficult to conceive with traditional methods. The company’s cutting tool products are already usable for machining robot components, such as the processing of parts including ball screws, reducers, and planetary wheels. In the future, the company will continue to optimize and develop related cutting tool products and increase its layout in providing end-to-end solutions for machining robot core components.

In addition, among the listed companies that received institutional research visits in the first quarter, four more doubling stocks emerged: Hongjing Technology, MinoVana, Kewchuan Technology, and Baichuan Shares. Their share-price gains in the first quarter were 131.21%, 112.58%, 107.99%, and 102.23%, respectively. From an industry distribution perspective, these four stocks belong to the computer, biopharmaceuticals, electronics, and chemical raw materials industries, respectively. The research meeting minutes disclosed by these companies show that topics of interest to institutions include how the company’s overseas business is progressing, the development history and current trends in the small-nucleic-acid drug market, how to view the industry prospects for the company’s sector, and whether the reported price increases for the company’s chemical products are true, among other questions.

Judging by the share-price gain situation of listed companies that received institutional research visits in the first quarter, the stocks with the highest gains were relatively concentrated in growth-style sectors such as biopharmaceuticals and electronics. From the performance of A-share industry sectors on April 1, the biopharmaceuticals industry topped the 31 Shenwan primary industries with nearly 4% growth. The electronics industry also performed strongly, rising by nearly 3% for the full day, ranking just behind biopharmaceuticals, communications, and media, and placing fourth among the 31 Shenwan primary industries.

（Source: China Securities Journal）